Karen Miller Kovach , its chief scientist, says the decision was made because there's no long-term data to show that weight-loss programs for children work.
Nissen then walked through a series of slides arguing diabetes drugs are approved with almost no long-term data in patients with heart disease--even though, after approval, heart patients get the drugs for a long time.